Association of Proton Pump Inhibitor Use With Incident Dementia and Cognitive Decline in Older Adults: A Prospective Cohort Study

被引:7
|
作者
Mehta, Raaj S. [1 ,2 ]
Kochar, Bharati [1 ,2 ]
Zhou, Zhen [3 ]
Broder, Jonathan C. [4 ]
Chung, Paget [1 ,2 ]
Yang, Keming [1 ,2 ]
Lockery, Jessica [4 ]
Fravel, Michelle [5 ,6 ]
Ryan, Joanne [4 ]
Mahady, Suzanne [4 ]
Orchard, Suzanne G. [4 ]
Mcneil, John J. [4 ]
Murray, Anne [4 ]
Woods, Robyn L. [4 ]
Ernst, Michael E. [5 ,6 ]
Chan, Andrew T. [1 ,2 ,7 ,8 ]
机构
[1] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Univ Tasmania, Menzies Inst Med Res, Hobart, Australia
[4] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Australia
[5] Univ Iowa, Coll Pharm, Dept Pharm Practice & Sci, Iowa City, IA USA
[6] Univ Iowa, Carver Coll Med, Dept Family Med, Iowa City, IA USA
[7] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA
[8] Harvard Med Sch, Massachusetts Gen Hosp, Gastroenterol Unit, 55 Fruit St, GRJ 825C, Boston, MA 02114 USA
基金
美国国家卫生研究院; 英国医学研究理事会;
关键词
Proton Pump Inhibitors; Dementia; Pharmacoepidemiology; Cognition; DISEASE; RISK;
D O I
10.1053/j.gastro.2023.05.052
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Prior studies have suggested that proton pump inhibitor (PPI) use is associated with increased risk of dementia; however, these have been limited by incomplete assessment of medication use and failure to account for confounders. Furthermore, prior studies have relied on claims-based diagnoses for dementia, which can lead to misclassification. We investigated the associations of PPI and histamine-2 receptor antagonist (H2RA) use with dementia and cognitive decline. METHODS: We conducted a post hoc analysis of ASPirin in Reducing Events in the Elderly (ASPREE), a randomized trial of aspirin in the United States and Australia, including 18,934 community-based adults >65 years of all races/ethnicities. Baseline and recent PPI and H2RA use were determined according to review of medications during annual in-person study visits. Incident dementia was defined according to Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition, criteria. Secondaryendpoints include cognitive impairment, no dementia (CIND) and changes in cognition. Associations of medication use with dementia and CIND outcomes were examined using Cox proportional hazards models. Changes in cognitive test scores were examined using linear mixed-effects models.RESULTS: Baseline PPI use vs nonuse was not associated with incident dementia (multivariable hazard ratio, 0.88; 95% confidence interval, 0.72-1.08), CIND (multivariable hazard ratio, 1.00; 95% confidence interval, 0.92-1.09), or with changes in overall cognitive test scores over time (multivariable B, -0.002; standard error, 0.01; P 1/4 .85). Similarly, no associations were observed between H2RA use and all cognitive endpoints.CONCLUSIONS: In adults >65 years of age, PPI and H2RA use were not associated with incident dementia, CIND, or decline in cognition over time. These data provide reassurance about the safety of long-term use of PPIs among older adults.
引用
收藏
页码:564 / +
页数:10
相关论文
共 50 条
  • [41] Motoric Cognitive Risk and Incident Dementia in Older Adults
    Chung, Jeehae
    Byun, Seonjeong
    JAMA NETWORK OPEN, 2023, 6 (10)
  • [42] Association between housework and the risk of dementia among older Chinese adults: a prospective cohort study
    Wang, Yuanlong
    Luo, Xinxin
    Long, Xiangyun
    Shao, Yuan
    Zhang, Song
    Zhang, Yingli
    Wang, Yongjun
    FRONTIERS IN PSYCHOLOGY, 2023, 14
  • [43] Association between delirium superimposed on dementia and mortality in hospitalized older adults: A prospective cohort study
    Avelino-Silva, Thiago J.
    Campora, Flavia
    Curiati, Jose A. E.
    Jacob-Filho, Wilson
    PLOS MEDICINE, 2017, 14 (03):
  • [44] Metformin Use Is Associated With Slowed Cognitive Decline and Reduced Incident Dementia in Older Adults With Type 2 Diabetes: The Sydney Memory and Ageing Study
    Samaras, Katherine
    Makkar, Steve
    Crawford, John D.
    Kochan, Nicole A.
    Wen, Wei
    Draper, Brian
    Trollor, Julian N.
    Brodaty, Henry
    Sachdev, Perminder S.
    DIABETES CARE, 2020, 43 (11) : 2691 - 2701
  • [45] Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan
    Tai, Shu-Yu
    Chien, Chen-Yu
    Wu, Deng-Chyang
    Lin, Kun-Der
    Ho, Bo-Lin
    Chang, Yu-Han
    Chang, Yang-Pei
    PLOS ONE, 2017, 12 (02):
  • [46] Proton pump inhibitor use and the risk of fractures among an older adult cohort
    Harding, Barbara N.
    Weiss, Noel S.
    Walker, Rod L.
    Larson, Eric B.
    Dublin, Sascha
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 (06) : 596 - 603
  • [47] Association of multiple metabolic and cardiovascular markers with the risk of cognitive decline and mortality in adults with Alzheimer's disease and AD-related dementia or cognitive decline: a prospective cohort study
    Liu, Longjian
    Gracely, Edward J.
    Zhao, Xiaopeng
    Gliebus, Gediminas P.
    May, Nathalie S.
    Volpe, Stella L.
    Shi, Jingyi
    DiMaria-Ghalili, Rose Ann
    Eisen, Howard J.
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [48] Macronutrients Intake and Incident Frailty in Older Adults: A Prospective Cohort Study
    Sandoval-Insausti, Helena
    Perez-Tasigchana, Raul F.
    Lopez-Garcia, Esther
    Garcia-Esquinas, Esther
    Rodriguez-Artalejo, Fernando
    Guallar-Castillon, Pilar
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2016, 71 (10): : 1329 - 1334
  • [49] Association of Dilated Perivascular Spaces With Cognitive Decline and Incident Dementia
    Paradise, Matthew
    Crawford, John D.
    Lam, Ben C. P.
    Wen, Wei
    Kochan, Nicole A.
    Makkar, Steve
    Dawes, Laughlin
    Trollor, Julian
    Draper, Brian
    Brodaty, Henry
    Sachdev, Perminder S.
    NEUROLOGY, 2021, 96 (11) : E1501 - E1511